Advances in thymosin beta10 research: differential expression, molecular mechanisms, and clinical implications in cancer and other conditions.
about
A loss of FUS/TLS function leads to impaired cellular proliferationMicroscopy ambient ionization top-down mass spectrometry reveals developmental patterningHigh expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.Mobile elements and viral integrations prompt considerations for bacterial DNA integration as a novel carcinogenReduced myelin basic protein and actin-related gene expression in visual cortex in schizophreniaSuppression of thymosin β10 increases cell migration and metastasis of cholangiocarcinoma.T-2 toxin induced Salmonella Typhimurium intoxication results in decreased Salmonella numbers in the cecum contents of pigs, despite marked effects on Salmonella-host cell interactions.Immunoreactivity for thymosin beta 4 and thymosin beta 10 in the adult rat oro-gastro-intestinal tract.Hypomethylation of the thymosin β(10) gene is not associated with its overexpression in non-small cell lung cancer.Thymosin beta 4 and thymosin beta 10 expression in hepatocellular carcinoma.Thymosin beta-10 expression in developing human kidney.A multicenter photoprovocation study to identify potential biomarkers by global peptide profiling in cutaneous lupus erythematosus.Expression of cyclophilin A in gastric adenocarcinoma patients and its inverse association with local relapses and distant metastasis.Deer thymosin beta 10 functions as a novel factor for angiogenesis and chondrogenesis during antler growth and regeneration.
P2860
Q27331026-4F731954-AB76-42AC-8361-F2FC64BC807FQ30544877-97C1CFEA-A6CC-4BF8-92C7-D64CD25F7B8FQ33961903-57F01F40-25E2-44F0-824F-306AAD49D1D4Q34053726-62560FF4-8DBA-42EF-849D-DCBE4F5B2580Q34295745-B2EFA0B4-2840-479A-9240-A62E9F78F4CDQ34992935-E4F43A4C-D76C-4718-B6EF-2586A8A16391Q35996374-EF0B33C0-A471-4E4C-95AF-3D838A195B5FQ37224104-7BF78EAB-3E44-4029-9015-290BA0276B00Q37461190-1E9667D0-583E-4615-871F-C2B16BFDA62EQ37693078-919132B2-69BB-4C8D-AF0A-A55AF9ADCE2CQ45867334-58F20700-A4DE-4F0E-8931-01BCFDB32C1DQ53410409-F70FEDCF-EAA8-4DA4-B465-6A6D519DA571Q54541938-7A39F5C0-F065-4877-A6F7-F672DDFB6035Q55428008-3AEFC0FE-847A-4016-842E-6CFC42642BA4
P2860
Advances in thymosin beta10 research: differential expression, molecular mechanisms, and clinical implications in cancer and other conditions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advances in thymosin beta10 re ...... n cancer and other conditions.
@en
Advances in thymosin beta10 re ...... n cancer and other conditions.
@nl
type
label
Advances in thymosin beta10 re ...... n cancer and other conditions.
@en
Advances in thymosin beta10 re ...... n cancer and other conditions.
@nl
prefLabel
Advances in thymosin beta10 re ...... n cancer and other conditions.
@en
Advances in thymosin beta10 re ...... n cancer and other conditions.
@nl
P2093
P2860
P1433
P1476
Advances in thymosin beta10 re ...... n cancer and other conditions.
@en
P2093
Chaisiri Wongkham
Changyi Chen
Sirinapa Sribenja
Sopit Wongkham
P2860
P304
P356
10.3109/07357900902849640
P577
2009-12-01T00:00:00Z